Drug benefit underfunded--report
Wagner, L.
Modern Healthcare 19(20): 26
1989
ISSN/ISBN: 0160-7480 PMID: 10303568 Document Number: 329562
Document emailed within 1 workday
Related Documents
Gardner, J. 1999: Pharmacists join drug benefit debate. if Medicare offers prescription drug benefit, pharmacists want to be reimbursed Modern Healthcare 29(49): 6Geyman, J.P. 1980: Health services research: a crucial and underfunded need Journal of Family Practice 11(2): 195-196
Flyckt, L.; Rydberg, U.; Ågren, H. 2014: Swedish psychiatric research severely underfunded Lakartidningen 111(11): 444-445
Gallegos, A. 2014: Michigan brain drain: how many physicians are we losing from underfunded GME? Michigan Medicine 113(1): 8-12
Scott, L. 1995: AmHS to negotiate drug-benefit alliance Modern Healthcare 25(40): 10
Penna, P. 2004: Outcomes research in the Medicare drug benefit Managed Care Interface 17(1): 19-20
Cundiff, D.K. 2003: Medicare prescription drug benefit realities Medgenmed: Medscape General Medicine 5(4): 28
Wilensky, G.R. 2006: Implementing the Medicare drug benefit--the first 90 days Healthcare Financial Management: Journal of the Healthcare Financial Management Association 60(6): 42-43
Bower, P. 2009: Drug prevention of hypertension. All cause absolute benefit? Bmj 338: B2597
Toivonen, L.; Heikkilä, J. 1986: Drug therapy of arrhythmia--ECG, a "cosmetic" or benefit to the patient? Duodecim; Laaketieteellinen Aikakauskirja 102(22): 1651-1661
Tieman, J. 2003: Senior citizens score win as drug benefit advances Modern Healthcare 33(24): 8-9
Cook, A.E. 1999: Strategies for containing drug costs: implications for a Medicare benefit Health Care Financing Review 20(3): 29-37
2006: Pegaptanib: new drug. In macular degeneration: too many risks for too little benefit Prescrire International 15(84): 127-129
Toivonen, L.; Heikkilä, J. 1987: Drug treatment of arrhythmias -- cosmetics of the ECG or benefit to the patient Annals of Clinical Research 19(1): 1-4
Hoffman, R.M. 2000: The clinical benefit of the histoculture drug response assay Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 321-322
Bengt, J.ön.; Arvidsson, G.ör.; Levin, L.-A.; Rehnberg, C. 2005: Drug utilization decisions should be based on cost-benefit data Lakartidningen 102(16): 1264-1265; Discussion 1265
Demarez, J.P.; Couzinier, J.P.; Begaud, B. 1985: Drug surveillance. Establishment of a benefit/risk ratio in current practice Therapie 40(5): 333-335
Gardner, J. 2001: Double the money. Lawmakers exceed Bush budget request for Medicare reform, drug benefit Modern Healthcare 31(19): 8-9
Nyssen, A.; Legrand, V.; Scheen, A.J. 2008: Benefit-risk ratio of coronary drug-eluting stents: 2nd part: evaluation in the diabetic population Revue Medicale de Liege 63(11): 654-661
Shore, M F. 1975: Review of Existing patterns of services for alcoholism and drug dependence: Report of a study; Comparison and evaluation of methods of treatment and rehabilitation for drug dependence and abuse: Report on a working group; Psychiatry and primary medical care: Report on a working group; and The role of the psychologist in mental health services: Report on a working group American Journal of Orthopsychiatry 45(3): 505-506